Replimune

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Replimune and other ETFs, options, and stocks.

About REPL

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. 

CEO
Sushil Patel
CEOSushil Patel
Employees
465
Employees465
Headquarters
Woburn, Massachusetts
HeadquartersWoburn, Massachusetts
Founded
2015
Founded2015
Employees
465
Employees465

REPL Key Statistics

Market cap
2.03B
Market cap2.03B
Price-Earnings ratio
-7.34
Price-Earnings ratio-7.34
Dividend yield
—
Dividend yield—
Average volume
3.11M
Average volume3.11M
High today
—
High today—
Low today
—
Low today—
Open price
$21.94
Open price$21.94
Volume
0.00
Volume0.00
52 Week high
$23.54
52 Week high$23.54
52 Week low
$1.50
52 Week low$1.50

Stock Snapshot

Replimune(REPL) stock is priced at $21.30, giving the company a market capitalization of 2.03B. It carries a P/E multiple of -7.34.

On 2026-11-17, Replimune(REPL) stock opened at $21.94, reached a high of —, and a low of —.

Replimune(REPL) shares are trading with a volume of 0, against a daily average of 3.11M.

During the past year, Replimune(REPL) stock moved between $1.50 at its lowest and $23.54 at its peak.

During the past year, Replimune(REPL) stock moved between $1.50 at its lowest and $23.54 at its peak.

REPL News

TipRanks 2d
Replimune Earnings Call Highlights Rapid TUDRIQEV Launch

Replimune Group ((REPL)) has held its Q2 earnings call. Read on for the main highlights of the call. Replimune’s earnings call carried a strongly positive tone...

Simply Wall St 3d
Replimune Group On TUDRIQEV Approval And Why Valuation Still Divides Views

Replimune Group (REPL) has attracted investor attention after a sharp share price move over the past month, with the stock up about 92% and roughly 46% over the...

Replimune Group On TUDRIQEV Approval And Why Valuation Still Divides Views

Analyst ratings

100%

of 8 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own REPL. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.